<DOC>
	<DOC>NCT00339872</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety of, and blood drug levels for, single, ascending doses of IMA-638 in mild to moderate asthma subjects.</brief_summary>
	<brief_title>Study Evaluating IMA-638 in Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Men and women of nonchildbearing potential with mild to moderate asthma as defined by forced expiratory volume in 1 second (FEV1) greater than 70% predicted. Well controlled asthma, as exhibited by completion of asthma questionnaire. Otherwise healthy, except for asthma.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>healthy subjects</keyword>
</DOC>